SciELO - Scientific Electronic Library Online

 
vol.6 número10De las nanobiomoléculas a la nanobiología y nanomedicinaGestionando entornos sociotécnicos complejos: la gobernanza del riesgo en las nanotecnologías índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Mundo nano. Revista interdisciplinaria en nanociencias y nanotecnología

versión On-line ISSN 2448-5691versión impresa ISSN 2007-5979

Resumen

DELGADO RAMOS, Gian Carlo  y  HERNANDEZ BURCIAGA, Luis Alberto. Avances e implicaciones éticosociales de la nanomedicina: una revisión desde el caso del cáncer cerebral. Mundo nano [online]. 2013, vol.6, n.10, pp.63-85.  Epub 23-Jun-2021. ISSN 2448-5691.  https://doi.org/10.22201/ceiich.24485691e.2013.10.50965.

Health applications are among the most promising and dynamic of nanotechnology innovation. To highlight are those focused on cancer, HIV-AIDS, diabetes, osteoarthritis, degenerative diseases, and cardiovascular and nervous disorders. This paper deals with nanoapplications for brain cancer. It starts with a brief introduction about current state of research and development of nanotechnology and its medical applications, particularly from an economic perspective. It then briefly presents cancer and brain cancer diseases, current challenges of diagnosis and treatment and nanotechnology potential to solve them. After a review of more than three thousand papers registered in PubMed database (from 2000 to 2013), an analysis of the progress of nanorelated research in cancer is offered. It includes a general description of types of cancers, including brain cancer, and nanostructures currently being studied. Finally, a reflection on potential risks associated with direct exposure to nanomaterials, as well as on social and ethical implications of the progress of nanomedicine is presented. By outlining a normative model of an integrated management and distribution of risk, we argue the relevance of democratically and responsibly promoting and regulating nanotechnology in general and nanomedicine in particular; all with the purpose of minimizing eventual costs and unnecessary risks.

Palabras llave : nanomedicine; brain cancer; social aspects; ethical regulation.

        · resumen en Español     · texto en Español     · Español ( pdf )